310 related articles for article (PubMed ID: 34684463)
1. Relationship between Dietary Fatty Acid Intake with Nonalcoholic Fatty Liver Disease and Liver Fibrosis in People with HIV.
de Almeida CF; da Silva PS; Cardoso CSA; Moreira NG; Antunes JC; de Andrade MM; Silva J; Araujo MC; Peres WAF; do Brasil PEAA; Moreira RI; Cardoso SW; Veloso VG; Grinsztejn B; de Brito PD; Perazzo H
Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684463
[TBL] [Abstract][Full Text] [Related]
2. Nonalcoholic fatty liver disease diagnosed by transient elastography with controlled attenuation parameter in unselected HIV monoinfected patients.
Vuille-Lessard É; Lebouché B; Lennox L; Routy JP; Costiniuk CT; Pexos C; Giannakis A; Szabo J; Klein MB; Sebastiani G
AIDS; 2016 Nov; 30(17):2635-2643. PubMed ID: 27603289
[TBL] [Abstract][Full Text] [Related]
3. "Dangerous liaisons: NAFLD and liver fibrosis increase cardiovascular risk in HIV".
Cervo A; Sebastiani G; Milic J; Krahn T; Mazzola S; Petta S; Cascio A; Guaraldi G; Mazzola G
HIV Med; 2022 Sep; 23(8):911-921. PubMed ID: 35199429
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of serological biomarkers for detection of non-alcoholic fatty liver disease (NAFLD) and/or advanced liver fibrosis in people living with HIV.
Yanavich C; Pacheco AG; Cardoso SW; Nunes EP; Chaves U; Freitas G; Santos R; Morata M; Veloso VG; Grinsztejn B; Perazzo H
HIV Med; 2021 Jul; 22(6):445-456. PubMed ID: 33529485
[TBL] [Abstract][Full Text] [Related]
5. Dietary consumption and serum pattern of bioactive fatty acids in NAFLD patients.
López-Bautista F; Barbero-Becerra VJ; Ríos MY; Ramírez-Cisneros MÁ; Sánchez-Pérez CA; Ramos-Ostos MH; Uribe M; Chávez-Tapia NC; Juárez-Hernández E
Ann Hepatol; 2020; 19(5):482-488. PubMed ID: 32717363
[TBL] [Abstract][Full Text] [Related]
6. Screening for Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Diseases: A Cohort Study Using Transient Elastography.
Saroli Palumbo C; Restellini S; Chao CY; Aruljothy A; Lemieux C; Wild G; Afif W; Lakatos PL; Bitton A; Cocciolillo S; Ghali P; Bessissow T; Sebastiani G
Inflamm Bowel Dis; 2019 Jan; 25(1):124-133. PubMed ID: 29889226
[TBL] [Abstract][Full Text] [Related]
7. Non-alcoholic fatty liver disease in HIV infection associated with altered hepatic fatty acid composition.
Arendt BM; Mohammed SS; Ma DW; Aghdassi E; Salit IE; Wong DK; Guindi M; Sherman M; Heathcote EJ; Allard JP
Curr HIV Res; 2011 Mar; 9(2):128-35. PubMed ID: 21434863
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and risk factors of metabolic associated fatty liver disease among people living with HIV in China.
Liu D; Shen Y; Zhang R; Xun J; Wang J; Liu L; Steinhart C; Chen J; Lu H
J Gastroenterol Hepatol; 2021 Jun; 36(6):1670-1678. PubMed ID: 33140878
[TBL] [Abstract][Full Text] [Related]
9. Dietary Composition and Its Association with Newly Diagnosed Nonalcoholic Fatty Liver Disease and Insulin Resistance.
Charatcharoenwitthaya P; Tansakul E; Chaiyasoot K; Bandidniyamanon W; Charatcharoenwitthaya N
Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959990
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic Fatty Liver Disease Among Individuals with HIV Mono-infection: A Growing Concern?
Morrison M; Hughes HY; Naggie S; Syn WK
Dig Dis Sci; 2019 Dec; 64(12):3394-3401. PubMed ID: 31643035
[TBL] [Abstract][Full Text] [Related]
11. Advanced Liver Fibrosis Is Independently Associated with Palmitic Acid and Insulin Levels in Patients with Non-Alcoholic Fatty Liver Disease.
Cansanção K; Silva Monteiro L; Carvalho Leite N; Dávalos A; Tavares do Carmo MDG; Arantes Ferreira Peres W
Nutrients; 2018 Oct; 10(11):. PubMed ID: 30380656
[TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: Beyond the natural history.
Magrì S; Paduano D; Chicco F; Cingolani A; Farris C; Delogu G; Tumbarello F; Lai M; Melis A; Casula L; Fantini MC; Usai P
World J Gastroenterol; 2019 Oct; 25(37):5676-5686. PubMed ID: 31602167
[TBL] [Abstract][Full Text] [Related]
13. Prevalence, Predictors, and Severity of Lean Nonalcoholic Fatty Liver Disease in Patients Living With Human Immunodeficiency Virus.
Cervo A; Milic J; Mazzola G; Schepis F; Petta S; Krahn T; Lebouche B; Deschenes M; Cascio A; Guaraldi G; Sebastiani G
Clin Infect Dis; 2020 Dec; 71(10):e694-e701. PubMed ID: 32280969
[TBL] [Abstract][Full Text] [Related]
14. Association between Dietary Vitamin C Intake and Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study among Middle-Aged and Older Adults.
Wei J; Lei GH; Fu L; Zeng C; Yang T; Peng SF
PLoS One; 2016; 11(1):e0147985. PubMed ID: 26824361
[TBL] [Abstract][Full Text] [Related]
15. Higher ultra-processed food intake is associated with adverse liver outcomes: a prospective cohort study of UK Biobank participants.
Zhao L; Clay-Gilmour A; Zhang J; Zhang X; Steck SE
Am J Clin Nutr; 2024 Jan; 119(1):49-57. PubMed ID: 37871746
[TBL] [Abstract][Full Text] [Related]
16. Food insecurity is associated with magnetic resonance-determined nonalcoholic fatty liver and liver fibrosis in low-income, middle-aged adults with and without HIV.
Tamargo JA; Sherman KE; Campa A; Martinez SS; Li T; Hernandez J; Teeman C; Mandler RN; Chen J; Ehman RL; Baum MK
Am J Clin Nutr; 2021 Mar; 113(3):593-601. PubMed ID: 33515016
[TBL] [Abstract][Full Text] [Related]
17. Risk stratification of patients with nonalcoholic fatty liver disease using a case identification pathway in primary care: a cross-sectional study.
Shaheen AA; Riazi K; Medellin A; Bhayana D; Kaplan GG; Jiang J; Park R; Schaufert W; Burak KW; Sargious M; Swain MG
CMAJ Open; 2020; 8(2):E370-E376. PubMed ID: 32414883
[TBL] [Abstract][Full Text] [Related]
18. Predictors of advanced fibrosis in non-cirrhotic non-alcoholic fatty liver disease in Germany.
Labenz C; Huber Y; Kalliga E; Nagel M; Ruckes C; Straub BK; Galle PR; Wörns MA; Anstee QM; Schuppan D; Schattenberg JM
Aliment Pharmacol Ther; 2018 Nov; 48(10):1109-1116. PubMed ID: 30288767
[TBL] [Abstract][Full Text] [Related]
19. Total polyunsaturated fatty acid intake and the risk of non-alcoholic fatty liver disease in Chinese Han adults: a secondary analysis based on a case-control study.
Xie Y; Tian H; Xiang B; Li D; Liu J; Cai Z; Liu Y; Xiang H
BMC Gastroenterol; 2021 Nov; 21(1):451. PubMed ID: 34847883
[TBL] [Abstract][Full Text] [Related]
20. Diets with Higher Anti-inflammatory Potential Associated with Lower Risk of Development of Nonalcoholic Fatty Liver Disease and Early-Stage of Fibrosis Among US Adults.
Li R; Li M; Bidulescu A; Fly AD; Luo J
Dig Dis Sci; 2023 Oct; 68(10):4009-4021. PubMed ID: 37535123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
